Advertisement

Treatment of Local Regional Disease

  • J. P. Donohue
Conference paper
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 126)

Abstract

Nonseminomatous germ cell tumor is an extraordinary tumor in terms of demonstrating the impact of regional lymphadenectomy on survival. Over the years many series have shown that node-positive (pathologic stage II) patients can be cured with local measures in excess of 50% of cases. There are a variety of anatomical considerations that make testicular lymphatic drainage predictable. These relate to features of anatomic descent of the gonad and its associated lymphatics. A number of topographic studies have supported the regional deposition of metastatic disease, and we have a good understanding of this. More importantly, there are biologic considerations that probably lend to the opportunity for cure of testis cancer patients with surgery alone. Many patients will have teratomatous elements which have somewhat lower metastatic potential. What is fascinating, however, is that even undifferentiated germ cell tumors, such as embryonal cancer, are often cured with lymphadenectomy alone. Data recently presented in a multiinstitutional cooperative study show that a control group treated with node dissection alone had more than half of the patients as long-term survivors without relapse [1].

Keywords

Germ Cell Tumor Testicular Cancer Testis Cancer Nonseminomatous Germ Cell Retroperitoneal Lymph Node Dissection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Williams SD et al. (1987) Immediate adjuvant chemotherapy versus observation with treatment of relapse in pathological stage II testicular cancer. N Engl J Med 317:1433–1438PubMedCrossRefGoogle Scholar
  2. 2.
    Donohue JP et al. (1988) Preservation of ejaculation following nerve-sparing retroperitoneal lymphadenectomy. J Urol 139:206A (abstr no 176)Google Scholar
  3. 3.
    Loehrer PJ, Williams SD, Clark SA et al. (1986) Teratoma following chemotherapy for nonseminomatous germ cell tumor (NSGCT): a clinicopathologic correlation. J Urol 135:1183PubMedGoogle Scholar
  4. 4.
    Einhorn LH, Williams SD, Mandelbaum I, Donohue JP (1981) Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduetion. Cancer 48:904–908PubMedCrossRefGoogle Scholar
  5. 5.
    Einhorn LH, Donohue JP (1977) Cis-diammine-dichloroplatinum, Vinblastine and Bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293–298PubMedGoogle Scholar
  6. 6.
    Donohue JP, Einhorn LH, Williams SD (1980) Cytoreductive surgery for metastatic testis cancer: considerations of timing and extent. J Urol 123:876–880PubMedGoogle Scholar
  7. 7.
    Donohue JP, Rowland RG (1984) The role of surgery in advanced testicular cancer. Cancer 54:2716–2721PubMedCrossRefGoogle Scholar
  8. 8.
    Loehrer PJ, Sledge GW, Einhorn LH (1985) Heterogeneity among germ cell tumors of the testis. Semin Oncol 12:304–316PubMedGoogle Scholar
  9. 9.
    Ulbright TM, Loehrer PJ, Roth LM et al. (1984) The development of non-germ cell malignancies within germ cell tumors: a clinicopathologic study of 11 cases. Cancer 54:1824–1833PubMedCrossRefGoogle Scholar
  10. 10.
    Donohue JP, Zachary JM, Maynard BR (1982) Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 128:315–320PubMedGoogle Scholar
  11. 11.
    Donohue JP, Rowland RG, Bihrle R (1988) Transabdominal retroperitoneal lymph node dissection. In: Skinner DG, Leiskovsky G (eds) Diagnosis and management of genitourinary cancer. Saunders, Philadelphia, pp 802–816Google Scholar
  12. 12.
    Donohue JP, Rowland RG (1981) Complications of Retroperitoneal Lymphadenectomy. J Urol 125:338PubMedGoogle Scholar
  13. 13.
    Donohue JP, Foster RS, Rowland RG et al. (1991) Nerve-sparing retroperitoneal lymphadenectomy. J Urol (Submitted)Google Scholar
  14. 14.
    Lange PH, Chang WY, Fraley EE (1987) Fertility issues in the therapy of nonseminomatous testicular tumors. Urol Clin North Am 14:731–745PubMedGoogle Scholar
  15. 15.
    Bihrle R, Donohue JP, Foster RS (1988) Complications of retroperitoneal lymph node dissection. Urol Clin North Am 15:237–242PubMedGoogle Scholar
  16. 16.
    Hoskins P, Dilly S, Easton D (1986) Prognostic factors in stage I nonseminomatous germ, cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol 4:1031–1036Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • J. P. Donohue
    • 1
  1. 1.Department of Urology, University Hospital-A112Indiana University Medical CenterIndianapolisUSA

Personalised recommendations